Abridge Secures $250M Series D, Unveils New Contextual Reasoning Engine for Healthcare
Abridge, a leader in generative AI for clinical conversations, has secured a $250 million Series D funding round. This milestone comes as the company surpasses 100 deployments across major health systems in the United States. The Series D investment is co-led by Elad Gil and IVP, with additional contributions from Bessemer Venture Partners, California Health Care Foundation, CapitalG, CVS Health Ventures, K. Ventures, Lightspeed Venture Partners, NVentures (NVIDIA’s venture capital arm), Redpoint Ventures, Spark Capital, and SV Angel. This funding will accelerate the development of Abridge’s AI technology and expand its commercial growth, supporting a broader range of applications in healthcare.
“We’re excited about the potential of Abridge’s technology to improve clinical documentation across our care sites,” said Matt Kull, Executive Vice President and Chief Information and Digital Officer at Inova. “The quality of specialty-specific notes and Abridge’s ability to respond to clinician feedback with rigorous, tested enhancements stood out to us. Learning about the innovation that ensures notes are both clinically valuable and billing-compliant, along with its proven ROI at other institutions, has been compelling as we explore this solution.”
Abridge, recently named Best in KLAS for the Ambient AI segment, has launched its new Contextual Reasoning Engine—an AI architecture designed to create more clinically relevant and billable notes at the point of care. Healthcare systems today face the challenge of incomplete clinical notes that delay billing, resulting in wasted hours spent improving documents weeks or even months after patient visits. Abridge’s technology generates comprehensive, billable notes right at the point of care, streamlining administrative processes, reducing costs, and allowing doctors to focus more on patient care. Key features of Abridge’s Contextual Reasoning Engine include:
- Contextual Awareness: Integrates data from past patient encounters, health system-specific revenue cycle guidelines, and clinician documentation preferences to generate comprehensive, personalized notes.
- Precise Problem Detection: Accurately identifies and groups medical issues, aligning them with appropriate billing codes to simplify revenue cycle workflows. Integration with Epic’s Diagnosis Awareness Notes is underway as part of the Epic Workshop program.
- Actionable Outputs: Captures medical orders and integrates them into the electronic health record (EHR) for clinician review. This integration with Epic is also under development.
- Auditable Notes: Ensures AI-generated outputs are traceable to their source data, powered by Linked Evidence.
Somesh Dash, General Partner at IVP, explained, “Our health systems are remarkable for their scientific and clinical achievements but are burdened by bureaucratic processes and tedious labor. AI can transform this by simplifying revenue cycle rules around documentation, allowing clinicians to focus on patients while ensuring accurate documentation from the start. Abridge is leading this change with health systems across the country.”
Dr. Shiv Rao, Abridge’s CEO and Founder, shared, “The Abridge Contextual Reasoning Engine helps us deliver even greater value within our core documentation offering, integrating system and revenue cycle requirements into an orchestrated AI system. This investment supports our long-term goals and strengthens the research and development behind our approach.”
Abridge is currently deployed in over 100 large, complex healthcare systems across the U.S., including rural hospitals, children’s hospitals, academic centers, and nationally recognized cancer centers. It is used by clinicians in more than 28 languages and across a wide range of specialties and care settings.
About Abridge
Founded in 2018, Abridge aims to improve healthcare understanding by transforming medical conversations into clinically useful and billable documentation. The platform reduces administrative burden, alleviates clinician burnout, and enhances the patient experience. Abridge supports deep EHR integration, 28+ languages, and 50+ specialties, and is used in various care settings, including outpatient, emergency departments, and inpatient care.
Abridge’s enterprise-grade AI platform is the only solution that links AI-generated summaries to source data, ensuring clinicians can trust and verify the output. As a pioneer in generative AI for healthcare, Abridge is setting the industry standard for AI deployment in health systems.
Abridge has been recognized for its innovations, including Best in KLAS for the Ambient AI segment, TIME’s Best Inventions of 2024, the 2024 Forbes AI 50 list, and Fortune’s 2024 AI 50 Innovators.
